Recce Pharmaceuticals Ltd (ASX:RCE)
Australia · Delayed Price · Currency is AUD 0.3600
0.00 (0.00%)
Sep 2, 2026, 12:09 PM AEST
Recce Pharmaceuticals Market Cap
Recce Pharmaceuticals has a market cap or net worth of 107.81 million as of September 1, 2026. Its market cap has decreased by -11.24% in one year.
Market Cap
107.81M
Enterprise Value
105.78M
Revenue
9.94M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.36
ChartMarket Cap Chart
Since January 15, 2016, Recce Pharmaceuticals's market cap has increased from 20.55M to 107.81M, an increase of 424.68%. That is a compound annual growth rate of 16.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 107.81M | -42.65% |
| Dec 31, 2025 | 187.97M | 67.15% |
| Dec 31, 2024 | 112.46M | 3.19% |
| Dec 29, 2023 | 108.98M | -7.28% |
| Dec 30, 2022 | 117.53M | -34.34% |
| Dec 31, 2021 | 179.00M | -2.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dimerix | 165.11M |
| Actinogen Medical | 159.93M |
| Paradigm Biopharmaceuticals | 133.65M |
| Island Pharmaceuticals | 130.20M |
| Alterity Therapeutics | 109.84M |
| LTR Pharma | 91.80M |
| Avecho Biotechnology | 88.87M |
| Immutep | 73.69M |